SCHEMBL22985308

SCHEMBL22985308

N#Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(C#N)c2-c2c(-c3ccc(C(F)(F)F)cc3C#N)cccc2-n2c3ccccc3c3cc(-c4ccc(C#N)cc4C#N)ccc32)c(C#N)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
GABRA1 P14867 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 3/20 0.33
PTPN5 P54829 1/20 0.32
MAT2A P31153 1/20 0.32
AR P10275 4/20 0.32
KIF11 P52732 2/20 0.32
XDH P47989 1/20 0.32
STS P08842 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985324 0.96 ALOX5AP (0.39) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22985428 0.95 ALOX5AP (0.39) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL20848878 0.94 AR (0.34) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22984986 0.94 KIF11 (0.37) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22985646 0.94 KIF11 (0.33) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22985426 0.92 ALOX5AP (0.40) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL20849611 0.91 GABRA1 (0.33) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22985666 0.91 ALOX5AP (0.36) ALOX5APFEN1GABRA1GABRG2GABRB3
SCHEMBL22985447 0.90 AR (0.39) ALOX5APFEN1PTPN5ARKIF11
SCHEMBL20848818 0.90 ALOX5AP (0.35) ALOX5APFEN1GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885GABRA1 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.